April 10 Repros Therapeutics Inc -
* Repros names Larry Dillaha, M.D., its permanent president and ceo
* Dillaha has also been named to board, filling an existing vacancy
* Dillaha was previously chief executive officer of Cavtherx, an inception stage biotechnology company
* Dillaha has been serving as president, chief executive officer on an interim basis since February 1, 2017 Source text for Eikon: Further company coverage:
ChargePoint secures $43 million in funding led by Siemens
SAN FRANCISCO, June 28 Electric vehicle charging station maker ChargePoint Inc said on Wednesday it had secured $43 million in financing led by German engineering group Siemens AG, bringing to a close the U.S. company's latest funding round at $125 million.